ACTAMAX

Active ingredients

The drug ACTAMAX contains one active pharmaceutical ingredient (API):

UNII OFG5EXG60L - RISEDRONATE SODIUM

Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved.

Read about Risedronic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
M05BA07
Risedronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA07

Authorization and marketing

This brand name is authorized in the following countries: South Africa

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
ZA
Health Products Regulatory Authority
Identifier(s): 42/3.2/0454, 42/3.2/0455